feed,title,long_url,short_url
Benzinga,Nicotinamide Mononucleotide Market Projected to Surpass 146.1 million USD and Grow at a 6.22% CAGR During the 2022-2027 Forecast Timeframe [117 Pages Report],https://benzinga.com/pressreleases/22/10/g29230200/nicotinamide-mononucleotide-market-projected-to-surpass-146-1-million-usd-and-grow-at-a-6-22-cagr-,
